We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Public Health

Public Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Academic vs. Industry: Why Non-Industry Trials Are Failing to Reach the Finish Line
Internal Medicineclinical trialsEvidence-Based Medicine

Academic vs. Industry: Why Non-Industry Trials Are Failing to Reach the Finish Line

By MedXY|Dec 20, 2025

A systematic review of 347 randomized trials reveals that non-industry-sponsored trials lag significantly behind industry counterparts in registration and results publication, with nearly one-third of all trials discontinued prematurely due

Why Our Strength and Fitness Peak in Our 20s–30s — and How Exercise Can Push Back the Clock
Internal Medicineagingexercise

Why Our Strength and Fitness Peak in Our 20s–30s — and How Exercise Can Push Back the Clock

By MedXY|Dec 20, 2025

A 47-year study shows physical capacity peaks in the late 20s–30s and accelerates downward from about age 40 — but regular exercise, started at any age, can meaningfully delay decline.

High-Dose Influenza Vaccine Fails to Significantly Reduce Combined Influenza and Pneumonia Hospitalizations: Insights from the DANFLU-2 Trial
Infectious Diseasesgeriatricshospitalization

High-Dose Influenza Vaccine Fails to Significantly Reduce Combined Influenza and Pneumonia Hospitalizations: Insights from the DANFLU-2 Trial

By MedXY|Dec 18, 2025

The DANFLU-2 trial found that while high-dose influenza vaccines significantly reduced influenza-specific hospitalizations in older adults, they did not reach statistical significance for the combined primary endpoint of influenza or pneumo

Electronic Cigarettes for Smoking Cessation: An Updated Review
newseffectivenesselectronic cigarettes

Electronic Cigarettes for Smoking Cessation: An Updated Review

By MedXY|Dec 18, 2025

This review examines the safety and effectiveness of electronic cigarettes as aids to quit smoking, showing increased abstinence rates compared to traditional therapies and no significant serious adverse events reported.

Nicotine E-Cigarettes Show Higher Quit Rates Than Traditional Nicotine Replacement Therapy
newselectronic cigarettesnicotine replacement therapy

Nicotine E-Cigarettes Show Higher Quit Rates Than Traditional Nicotine Replacement Therapy

By MedXY|Dec 17, 2025

Updated Cochrane review finds nicotine e-cigarettes increase smoking cessation success compared to NRT and non-nicotine e-cigarettes, with no clear difference in serious adverse events.

HPV Vaccination Significantly Reduces Precancerous Lesions and Anogenital Warts: Evidence from a Network Meta‑Analysis
Infectious Diseasesprecancerous lesions

HPV Vaccination Significantly Reduces Precancerous Lesions and Anogenital Warts: Evidence from a Network Meta‑Analysis

By MedXY|Dec 17, 2025

A large network meta‑analysis confirms HPV vaccines effectively reduce CIN2+ and anogenital warts, with no major safety concerns.

Most Very Preterm Infants Require Hospital Readmission Before Age 2 — Neonatal Morbidities Strongly Increase Days Spent in Hospital
newsneonatal morbidityrehospitalization

Most Very Preterm Infants Require Hospital Readmission Before Age 2 — Neonatal Morbidities Strongly Increase Days Spent in Hospital

By MedXY|Dec 15, 2025

A national cohort study from England and Wales found two-thirds of infants born <32 weeks’ gestation had ≥1 hospital admission before age 2, with lower gestational age and neonatal morbidities (BPD, severe NEC, brain injury) substantiall

Enhancing Access to Mifepristone via Community Pharmacies: Evidence from Routine Prescription Regulation in British Columbia, Canada
Clinical Updateshealthcare disparities

Enhancing Access to Mifepristone via Community Pharmacies: Evidence from Routine Prescription Regulation in British Columbia, Canada

By MedXY|Dec 15, 2025

This review synthesizes data on mifepristone availability at community pharmacies in BC, highlighting geographic coverage, dispensing gaps, and disparities influencing timely access to medication abortion.

Early-Life Famine Exposure in Chinese Immigrants Strongly Linked to Later Diabetes and Hypertension — But Not Cardiovascular Hospitalization
Diabetes & EndocrinologyHypertensiontype 2 diabetes

Early-Life Famine Exposure in Chinese Immigrants Strongly Linked to Later Diabetes and Hypertension — But Not Cardiovascular Hospitalization

By MedXY|Dec 14, 2025

A large Ontario cohort study links early-life exposure to the Great Chinese Famine with higher adult risks of type 2 diabetes and hypertension among Chinese immigrants, while cardiovascular hospitalization was not increased; methodological

Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial
Diabetes & Endocrinologyclinical trialdiabetes

Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial

By MedXY|Dec 13, 2025

This clinical trial evaluated monthly grocery vouchers for improving diabetes control in food-insecure patients, finding increased self-reported fruit and vegetable intake but no significant HbA1c improvement.

School Feeding Programs: Comprehensive Evidence on Benefits for Socioeconomically Disadvantaged School Children’s Physical and Psychological Health
Clinical Updateseducational outcomessocioeconomic disadvantage

School Feeding Programs: Comprehensive Evidence on Benefits for Socioeconomically Disadvantaged School Children’s Physical and Psychological Health

By MedXY|Dec 12, 2025

This review synthesizes global evidence, including meta-analyses, showing that school feeding programs modestly improve math achievement, enrollment, and growth metrics in socioeconomically disadvantaged children, with limited effects on re

Nucleoside-Modified mRNA Influenza Vaccine Prevents Symptomatic and Febrile Illness in a Human Challenge Model
Infectious Diseasesvaccine efficacy

Nucleoside-Modified mRNA Influenza Vaccine Prevents Symptomatic and Febrile Illness in a Human Challenge Model

By MedXY|Dec 6, 2025

A phase 2a human challenge trial found a nucleoside‑modified mRNA influenza vaccine provided complete protection against symptomatic and febrile A/H1N1 infection versus unvaccinated controls and reduced viral load versus control and QIV, wi

One Dose of HPV Vaccine Noninferior to Two: Implications for Global Cervical Cancer Prevention
Infectious Diseasescervical cancer preventionHPV vaccine

One Dose of HPV Vaccine Noninferior to Two: Implications for Global Cervical Cancer Prevention

By MedXY|Dec 3, 2025

A randomized trial of 20,330 girls 12–16 years shows one dose of bivalent or nonavalent HPV vaccine prevents persistent HPV16/18 infection as effectively as two doses over 5 years, with high effectiveness and no safety signals.

Elevated Blood Pressure in Adolescence Predicts Dose‑Dependent Coronary Atherosclerosis in Middle Age: Implications for Early Detection and Prevention
CardiologyatherosclerosisCoronary CTA

Elevated Blood Pressure in Adolescence Predicts Dose‑Dependent Coronary Atherosclerosis in Middle Age: Implications for Early Detection and Prevention

By MedXY|Dec 2, 2025

A Swedish cohort study of 10,222 men linked adolescent blood pressure to coronary atherosclerosis by CCTA ~40 years later; higher systolic BP in adolescence, even in the ‘elevated’ range, was associated with greater odds of severe (>50%)

Novel Type 1 and Type 3 Live Attenuated Oral Poliovirus Vaccines Show Comparable Safety, Immunogenicity, and Shedding to Sabin mOPV in First‑in‑Human Phase 1 Trial
Infectious Diseasesimmunogenicity

Novel Type 1 and Type 3 Live Attenuated Oral Poliovirus Vaccines Show Comparable Safety, Immunogenicity, and Shedding to Sabin mOPV in First‑in‑Human Phase 1 Trial

By MedXY|Dec 1, 2025

A multicentre phase 1 trial in healthy US adults found nOPV1 and nOPV3 were well tolerated and induced robust homotypic neutralising antibody responses with shedding profiles similar to Sabin monovalent OPV, supporting progression to phase

Sex-Specific Paths to Independent Ageing in China: Lifestyle Drives Men’s Gains, Social Conditions Drive Women’s
newsHealthy AgeingSex Differences

Sex-Specific Paths to Independent Ageing in China: Lifestyle Drives Men’s Gains, Social Conditions Drive Women’s

By MedXY|Dec 1, 2025

A 13-year national cohort shows that combined healthy lifestyles and favourable social determinants substantially increase years lived independently; men gain more from behavioural change while women gain more from improved social condition

Surgical Aortic Valve Replacement Emits Twice the CO2 of TAVR: What This Means for Practice and Policy
Cardiologyaortic stenosisSAVR

Surgical Aortic Valve Replacement Emits Twice the CO2 of TAVR: What This Means for Practice and Policy

By MedXY|Nov 29, 2025

A life cycle assessment found SAVR produces roughly double the carbon footprint of transcatheter aortic valve replacement (TAVR), with postoperative ICU and ward care as the main drivers. Results highlight opportunities to decarbonize cardi

Surgical aortic valve replacement produces about twice the carbon footprint of transcatheter approaches: clinical and stewardship implications
Cardiologyaortic valve replacementcarbon footprint

Surgical aortic valve replacement produces about twice the carbon footprint of transcatheter approaches: clinical and stewardship implications

By MedXY|Nov 29, 2025

A life cycle assessment found SAVR emits ~620–750 kg CO2e per case—roughly double OR- or cath-lab TAVR (~280–360 kg CO2e). ICU length of stay and postoperative care were the dominant contributors, highlighting targets for low-carbon periope

Daily High‑Dose Mosnodenvir Significantly Lowers DENV‑3 Viremia in a Human Challenge — Proof‑of‑Concept with Early Resistance Signals
Infectious Diseasesantiviral prophylaxisDengue

Daily High‑Dose Mosnodenvir Significantly Lowers DENV‑3 Viremia in a Human Challenge — Proof‑of‑Concept with Early Resistance Signals

By MedXY|Nov 27, 2025

In a phase 2a human challenge, high‑dose daily mosnodenvir substantially reduced DENV‑3 RNA burden versus placebo without serious adverse events, but treatment‑associated NS4B viral mutations emerged, highlighting efficacy and resistance co

Combining Food Biodiversity, Less Processing, and the EAT‑Lancet Diet Improves Nutrient Adequacy and Lowers Environmental Impact: Insights from 368,733 EPIC Participants
Family Medicine & NutritionEAT‑Lancetsustainability

Combining Food Biodiversity, Less Processing, and the EAT‑Lancet Diet Improves Nutrient Adequacy and Lowers Environmental Impact: Insights from 368,733 EPIC Participants

By MedXY|Nov 25, 2025

Multi-objective optimization in the EPIC cohort shows that modest gains in adherence to the EAT‑Lancet diet, increased plant species richness, and substitution of ultra‑processed foods with minimally processed foods can raise nutrient adequ

Prev
18 / 25
1…1617181920…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles